Antenatal Late Preterm Steroids (ALPS): A Randomized Placebo-Controlled TrialLEO 90100 Aerosol Foam Compared to Calcipotriol Plus Betamethasone Dipropionate Gel in Subjects With Psoriasis VulgarisCervical Interlaminar Versus Transforaminal Epidural Steroid InjectionBetamethasone Dosing Interval - 12 or 24 Hours?Antenatal Betamethasone Compared to Dexamethasone - "BETACODE TRIAL"Caesarean and CorticotherapyEffectiveness of Caudal Epidural Injections in Treatment of Chronic Low Back and Lower Extremity PainTreatment of Chronic Thoracic and Neck and Upper Extremity PainEfficacy and Safety of Betamethasone Microsphere in Patients With Macular Edema Following Branch Retinal Vein Occlusion (HIKARI)An Exploratory Psoriasis Plaque Test Study With LEO 29102 Plus Calcipotriol, Ointment, in Psoriasis VulgarisAmnion-Based Injections in the ShoulderLocal Steroid Treatment for Idiopathic Granulomatous Mastitis (LSTIGM)Treatment of FUS-Related ALS With Betamethasone - The TRANSLATE StudyKIDS-STEP_Betamethasone Therapy in Hospitalised Children With CAPEnstilar® Foam in the Treatment of Chronic Plaque Psoriasis in Patients With Skin of ColorComparison of Desloratadine Associated With Prednisolone Oral Solution Versus Dexchlorpheniramine Associated With Betamethasone for Persistent Allergic Rhinitis TreatmentLEO 90100 in the Treatment of Psoriasis VulgarisLEO 90100 Compared With Calcipotriol Plus Betamethasone Dipropionate Ointment, LEO 90100 Vehicle and Ointment Vehicle in Subjects With Psoriasis VulgarisLEO 90105 Ointment in Japanese Subjects With PsoriasisA Psoriasis Plaque Test Study With LEO 90100 Cutaneous Spray, Ointment, in Psoriasis VulgarisLumbar Epidural Steroid Injections for Spinal Stenosis Multicenter Randomized, Controlled Trial (LESS Trial)Clinical Trial to Assess Safety, Tolerability and the Pharmacodynamic Effect of Different Concentrations of a New Anti-inflammatory Substance in Subjects With Chronic Plaque PsoriasisIndia Dexamethasone and BetamethasoneEffect of Antenatal Corticosteroids on Neonatal Morbidity.1404003_OpenPsori.PlaqueTest to Eval.Eff.of Diff.Comp. to MapracoratEfficacy and Safety of Fucicort® Lipid Cream Compared to Combination Treatment With Fucidin® Cream Followed by Betamethasone (Lianbang Beisong®) Cream and Fucicort® Lipid Cream Vehicle in Clinically Infected Atopic Dermatitis/EczemaEffects of ACS in Twin With LPB: Study Protocol for a RCTA Clinical Trial Evaluating Efficacy and Safety of MC2-01 CreamEvaluation of Potential Development of Photoallergic Skin Reaction After Use of MC2-01 CreamClinical Trial to Assess Safety, Tolerability and the Pharmacodynamics Effect of Calcipotriol/Betamethasone Dipropionate in a New Administration Form in Subjects With Chronic Plaque Psoriasis.Efficacy and Safety of LEO 90100 Foam in Japanese Subjects With Psoriasis VulgarisThis Trial is a Randomised, Multicentre, Investigator-blind, Vehicle and Comparator-controlled, Parallel-group Trial With the Purpose of Evaluation Efficacy, Safety and Convenience of the MC2-01 CreamBetamethasone (Betapred®) as Premedication for Reducing Postoperative Vomiting and Pain After TonsillectomyEvaluation of the Vasoconstriction Properties of MC2-01 CreamTo Study Generic Calcipotriene and Betamethasone Dipropionate Topical Foam, 0.005%/0.064%, in the Treatment of Psoriasis Vulgaris (Plaque Psoriasis).Antenatal Betamethasone and the Risk of Neonatal HypoglycemiaComparative Effectiveness of Particulate Versus Nonparticulate Steroid Injections for Musculoskeletal ConditionsACTH vs Betamethasone in Hospitalized Patients With Acute GoutObservational Study in Patients With Nail Psoriasis Treated With Enstilar® to Assess the Severity Change and the Quality of Life
P4844
Calcipotriol/betamethasone dipropionate ointment in mild-to-moderate paediatric psoriasis: long-term daily clinical practice data in a prospective cohort.Calcipotriene-betamethasone dipropionate topical suspension in the management of psoriasis: a status report on available data with an overview of practical clinical application.Expert recommendations: the use of the fixed combination calcipotriol and betamethasone dipropionate gel for the topical treatment of psoriasis.Real-life treatment profile of calcipotriene and betamethasone dipropionate topical suspension in patients with psoriasis vulgaris.Safety and efficacy of calcipotriol plus betamethasone dipropionate gel in the treatment of scalp psoriasis in adolescents 12-17 years of ageSafety and efficacy of calcipotriene plus betamethasone dipropionate topical suspension in the treatment of extensive scalp psoriasis in adolescents ages 12 to 17 years.Superior efficacy of calcipotriene and betamethasone dipropionate aerosol foam versus ointment in patients with psoriasis vulgaris--A randomized phase II study.Effects of topical corticosteroids on cell proliferation, cell cycle progression and apoptosis: in vitro comparison on HaCaT.Efficacy and Safety of Calcipotriene Plus Betamethasone Dipropionate Aerosol Foam in Patients With Psoriasis Vulgaris--a Randomized Phase III Study (PSO-FAST).Calcipotriol plus betamethasone dipropionate gel compared with calcipotriol scalp solution in the treatment of scalp psoriasis: a randomized, controlled trial investigating efficacy and safety in a Chinese population.Treatment of paediatric scalp psoriasis with calcipotriene/betamethasone dipropionate scalp formulation: effectiveness, safety and influence on children's quality of life in daily practice.Efficacy and maintenance strategies of two-compound formulation calcipotriol and betamethasone dipropionate gel (Xamiol® gel) in the treatment of scalp psoriasis: results from a study in 885 patients.Pooled safety analysis of calcipotriol plus betamethasone dipropionate gel for the treatment of psoriasis on the body and scalp.Real-life effectiveness of once-daily calcipotriol and betamethasone dipropionate gel vs. ointment formulations in psoriasis vulgaris: 4- and 12-week interim results from the PRO-long study.Development of Betamethasone Dipropionate-Loaded Nanostructured Lipid Carriers for Topical and Transdermal DeliveryThe Role of Combination Calcipotriol plus Betamethasone Dipropionate Gel in the Treatment of Moderate-to-Severe Scalp Seborrhoeic DermatitisBalance of Treg versus T-effector cells during systemic treatment with adalimumab and topical treatment with calcipotriol-betamethasone dipropionate ointmentEvaluation of change in the skin concentration of tazarotene and betamethasone dipropionate based on drug-drug interaction for transdermal drug delivery in miniature pig
P921
Q61864931-525A8297-672E-4962-806E-846F0A857CB1Q61894203-927643B3-2858-4F20-B2C0-50215F195AECQ61908764-94895134-2667-428A-B088-EA545726540EQ61920820-9B4858D7-DEFC-405C-8F68-01903F38DFD3Q61922203-76BD9C62-9A54-432E-B618-02D20A6DE844Q61924370-CB2A69DF-206E-4818-8D6F-F7F7CB359B54Q61933264-A3140AF3-E290-43E6-83F3-CBC450A214C2Q61938698-EE0CF750-A9FC-47D4-9034-D38D9598E8E5Q61955754-EF27426D-330A-47E8-B57D-460DF6DF3B5CQ61956321-1C5F6A57-78B8-40FA-B822-BA523E9C3E1AQ62031385-3F205612-571F-4A44-8EF8-68E09707E660Q62031664-B2B6BD4F-35B0-4B2B-B5B1-822A2AD576C8Q62042628-669510CE-1B14-48D6-B720-5483E8297C64Q62814227-54B28903-1B61-435D-8618-0114DCD340D9Q62822961-A619E85B-EA7E-4EC3-A73F-3E1437E667D9Q63317533-33D8C217-2FE3-4725-87C2-72A12D76CABFQ63319898-879497C4-F736-4626-8106-8F5C8C735BCEQ63320207-F05969A5-C37C-47A3-8661-E7FDDA66CE1FQ63321889-491052DA-349D-4FC9-B05B-E641675443BDQ63335827-4EEC6DE5-CBC4-4097-961A-CD07035E40EBQ63340469-C755C248-5434-4981-B60B-F1949C79419EQ63392861-ACA72551-F147-487B-AF1D-9B78E57612A8Q63392975-18B88A74-CEAC-4DC2-AE11-955D9B53E867Q63401647-214403F2-D8BD-42D0-9B56-AE7116539FD0Q63402398-213A306F-1CEF-43D3-8F12-36D4D5148144Q63403953-655EFEB0-B7FD-4834-AC81-DEDEA1390BE7Q63571801-ACDC62DA-866F-4483-B7D0-DCE00FC6C3ADQ63572384-563C67A5-EBDA-4584-974B-F10E3DBB504CQ63579385-CDA93064-1EA6-4B77-81F6-31958D00AB53Q63579536-BF235D8E-1127-4136-9D51-FC896184BD3EQ63584448-A7CB11AE-C983-4421-964B-8D92DF4D7728Q63585512-4845C4CA-28D3-4DC5-BAC6-1E592B55B0ACQ63592924-9D4D53D8-3CF1-46F0-8487-FE06923EED4CQ63593008-C1FBFDC7-A018-4EE8-8BD7-0847C40D3AA7Q63595903-D5413CC4-09AB-4BED-A366-BBD59F667BBBQ63596549-B528E4F8-28C6-467B-9259-D342A506F3D9Q86285973-5AFF9ED9-5555-4483-A5BD-60AE8C0C588CQ87930711-1312DDA1-BE33-4DE7-BABF-590D6D9B2B05Q93704409-1C0A58F2-6111-4523-B03D-B4E71F37E2AD
P4844
Q30769599-9149BBBE-DE6E-4D63-89E2-382AE6726657Q30857210-9C8BF564-87A1-4825-A4EE-01ADE355E896Q34412891-2F35911C-99B2-4196-9354-55EBD1649D71Q34667605-9AF3651B-EA00-41C1-BACB-892D97259515Q34982047-20FAA50D-9DBD-4104-9A63-03B1CE0BC93CQ35817223-A9055D5D-E058-4188-B793-AC831BEF2DF7Q36635181-5DF725E3-035D-4013-83F6-11DF2BBCEFD8Q38923719-4400A741-5FF3-4935-B02B-FBAF4FBBE68BQ39179479-B998F87D-1852-4E5E-A5A6-18D23248D14FQ40816333-5BB3ECBE-2256-46FB-9684-04533F30DB8DQ43646014-C028BB63-11E2-4C2C-B82F-0AF06FA10746Q43714903-AC1E8BED-210B-4F4A-AD67-A8E784D421F2Q44288342-825FE07D-7EBB-4F02-8A3E-18F5AA0BB9D2Q48085635-43A66C02-801D-4F70-A587-D43BF340E2DAQ64088391-8190DBD1-584D-4A21-82DB-5791088FCE82Q64109640-84385001-83C7-4ACB-92EA-567DEDA7D60BQ85890156-7B547821-FD91-4BE7-B1AB-4D0D45419AEAQ86023538-80579609-AF22-4A6C-BD1C-3B6E51F80C5E
P921
description
betamethasone dipropionate
@ru
betamethasone
@pl
chemesch Verbindung
@lb
chemical compound
@en
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de
name
Betametazon dipropionat
@sh
Betametazon dipropionat
@sr
betamethasone dipropionate
@en
betamethasone valeraate
@pl
type
label
Betametazon dipropionat
@sh
Betametazon dipropionat
@sr
betamethasone dipropionate
@en
betamethasone valeraate
@pl
altLabel
9-Fluoro-11beta,17,21-trihydro ...... -3,20-dione-17,21-dipropionate
@en
Betamethasone 17,21-dipropionate
@en
prefLabel
Betametazon dipropionat
@sh
Betametazon dipropionat
@sr
betamethasone dipropionate
@en
betamethasone valeraate
@pl
P486
P592
P6366
P661
P662
P665
P683
P1579
P2017
CCC(=O)OCC(=O)[C@]1([C@H](C[C@ ...... O)C=C[C@@]43C)F)O)C)C)OC(=O)CC
P2067
P2115
N0000146955
P231
P232
P233
CCC(=O)OCC(=O)C1(C(CC2C1(CC(C3(C2CCC4=CC(=O)C=CC43C)F)O)C)C)OC(=O)CC